name: ZINC OXIDE 135.6 mg in 1 mL TOPICAL LOTION [Sunforgettable Total Protection Face Shield Bronze]


name: ZINC OXIDE 112 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 60 mg in 1 mL TOPICAL SPRAY [BABYGANICS SPF 50 Plus SUNSCREEN]


name: AMINOHIPPURIC ACID 1 g in 1 g NOT APPLICABLE POWDER


name: CHLORAMBUCIL 1 g in 1 g NOT APPLICABLE POWDER


name: IMATINIB MESYLATE 1 g in 1 g NOT APPLICABLE POWDER


name: PAROMOMYCIN SULFATE 1 kg in 1 kg NOT APPLICABLE POWDER


name: PREDNISOLONE SODIUM PHOSPHATE 1 kg in 1 kg NOT APPLICABLE POWDER


name: RIFABUTIN 1 g in 1 g NOT APPLICABLE POWDER


name: SECNIDAZOLE 1 kg in 1 kg NOT APPLICABLE POWDER


name: TYLOSIN 1 kg in 1 kg NOT APPLICABLE POWDER


name: Niacinamide 2.60 g in 130 mL TOPICAL LIQUID [AAPE Nutrient Facial Toner]


name: SERTRALINE HYDROCHLORIDE 1 g in 1 g NOT APPLICABLE POWDER


name: Adenosine 0.005 g in 0.55 g TOPICAL PATCH [FILL ME MICRO NEEDLE]


name: ZINC OXIDE 230 mg in 1 g TOPICAL LOTION [Raw Elements Eco Formula SPF30 Sample Packs]


name: Niacinamide 0.80 g in 40 mL / Adenosine 0.01 g in 40 mL TOPICAL LIQUID [AAPE Continuous Renewal Serum]


name: influenza A virus A/Idaho/07/2018 (H1N1) antigen / influenza A virus A/Indiana/08/2018 (H3N2) antigen / influenza B virus B/Iowa/06/2017 antigen / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen


name: camphor / dimethicone / lidocaine / menthol


name: dengue virus live antigen, CYD serotype 1 / dengue virus live antigen, CYD serotype 2 / dengue virus live antigen, CYD serotype 3 / dengue virus live antigen, CYD serotype 4


name: SUCTION TUBE ATTACHMENT DEVICE KENDALL #166004


name: CATHETER,INTERMITTENT,MAGIC3 14FR BARD #53814G


name: SET,INFUSION,FLOW REGULATOR,12IN STAT 2 #S2-12


name: SET,INFUSION AUTOSOFT 90 TANDEM #1002822


name: SET,INFUSION AUTOSOFT 30 TANDEM #1002825


name: SET,INFUSION AUTOSOFT 90 TANDEM #1002819


name: SET,INFUSION AUTOSOFT 90 TANDEM #1002818


name: SET,INFUSION AUTOSOFT 90 TANDEM #1002821


name: SET,INFUSION AUTOSOFT 90 TANDEM #1002820


name: SET,INFUSION AUTOSOFT 30 TANDEM #1002826


name: VAD DRIVELINE MAINTENANCE KIT CENTURION #DM650


name: TRACH STOMA TRACHEOFIX ADHESIVE STRIP LUMINAUD #63046


name: TRACH STOMA PROTECTOR,BUCHANAN LITE LUMINAUD #38220


name: DRESSING,TEGADERM ISLAND 2IN X 2.75IN 3M#3582


name: HEAT & MOISTURE EXCHANGER MALLINCKRODT #353U19004


name: URINE METER WITH CATHETER 16FR BARD #892816


name: CATHETER,FOLEY COUDE 16FR 30ML BARD#0100L-16


name: Two-Item Generalised Anxiety Disorder Scale


name: Prolonged Intermittent Renal Replacement Therapy


name: Sustained Low-Efficiency Daily Diafiltration


name: Hydrogen Deuterium Exchange-Mass Spectrometry


name: Observational Studies, Veterinary as Topic


name: lamivudine, tenofovir disoproxil fumarate drug combination


name: lidocaine-cetylpyridinium chloride drug combination


name: Computational Prediction of Drug-Target Interactions


name: Tumor Necrosis Factor-a (TNF-a) Antagonists


name: Tumor Necrosis Factor-a (TNF-a) Inhibitors


name: Tumor Necrosis Factor-a (TNF-a) Blockers


name: Thyrotroph Thyroid Hormone Sensitivity Index


name: Polymerase Acidic Endonuclease Inhibitor


name: Was there a History of Radiation Exposure


name: Aldosterone [Mass or Moles/volume] in Serum or Plasma


name: Aldosterone [Mass or Moles/volume] in Urine


name: Aldosterone [Mass or Moles/volume] in Serum or Plasma --supine


name: Androstanolone [Mass or Moles/volume] in Serum or Plasma


name: Bilirubin.direct [Mass or Moles/volume] in Serum or Plasma


name: Bilirubin.indirect [Mass or Moles/volume] in Serum or Plasma


name: Bilirubin.total [Mass or Moles/volume] in Body fluid


name: Cortisol [Mass or Moles/volume] in Serum or Plasma


name: Creatinine [Mass or Moles/volume] in Urine


name: Creatinine [Mass or Moles] in 24 hour Urine


name: Estrone (E1) [Mass or Moles/volume] in Serum or Plasma


name: Glucagon [Mass or Moles/volume] in Serum or Plasma


name: carBAMazepine [Mass or Moles/volume] in Serum or Plasma


name: Ethanol [Mass or Moles/volume] in Serum or Plasma


name: Bilirubin.total [Mass or Moles/volume] in Serum or Plasma


name: Estradiol (E2) [Mass or Moles/volume] in Serum or Plasma


name: HEPARIN NA 100UNT/ML (PF) LOCK FLUSH SOLN,SYRINGE,5ML


name: HEPARIN NA 100UNT/ML (PF) LOCK FLUSH SOLN,SYRINGE,3ML


name: HEPARIN NA 10UNT/ML (PF) LOCK FLUSH SOLN,SYRINGE,3ML


name: HEPARIN SODIUM 10 [USP'U] in 1 mL INTRAVENOUS INJECTION, SOLUTION (device)


name: Calcium [Mass or Moles/volume] in Serum or Plasma


name: Calcium [Mass or Moles/volume] in 24 hour Urine


name: Creatinine [Mass or Moles/volume] in 24 hour Urine


name: Ammonia [Mass or Moles/volume] in Plasma


name: Calcium [Mass or Moles/volume] corrected for total protein in Serum or Plasma


name: Cortisol Free [Mass or Moles/volume] in 24 hour Urine by HPLC


name: XR Hip - left Views and Lateral crosstable


name: XR Radius and Ulna - right Views and Oblique


name: XR Hip - right Views and Lateral crosstable


name: XR Tibia and Fibula - right Views and Oblique


name: Calcium.ionized [Mass or Moles/volume] in Serum or Plasma


name: Guidance for injection of Spine facet joint


name: CYP2D6 (cytochrome P450, family 2, subfamily D, polypeptide 6) (eg, drug metabolism) gene analysis, full gene sequence (List separately in addition to code for primary procedure)


name: Radiologic examination, esophagus, including scout chest radiograph(s) and delayed image(s), when performed; single-contrast (eg, barium) study


name: Radiologic examination, small intestine, including multiple serial images and scout abdominal radiograph(s), when performed; single-contrast (eg, barium) study


name: Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutical agent(s) (includes vascular flow and blood pool imaging, when performed); planar, whole body, single day imaging


name: Cytogenomic neoplasia (genome-wide) microarray analysis, interrogation of genomic regions for copy number and loss-of-heterozygosity variants for chromosomal abnormalities


name: Cytolethal distending toxin B (CdtB) and vinculin IgG antibodies by immunoassay (ie, ELISA)


name: Evaluation of biomarker antibodies for inflammatory bowel disease


name: Ambulatory blood pressure monitoring, utilizing report-generating software, automated, worn continuously for 24 hours or longer; recording only


name: Low-level laser therapy, dynamic photonic and dynamic thermokinetic energies, provided by a physician or other qualified health care professional


name: Immobilized Metal Affinity Chromatography


name: Stable Isotope Labeling with Amino Acids in Cell Culture


name: Chemokine (C-C Motif) Ligand 20 Measurement


name: Montreal Cognitive Assessment Naming Test


name: Chemokine (C-X-C Motif) Ligand 11 Measurement


name: Unspecified Cells to Leukocytes Ratio Measurement


name: Montreal Cognitive Assessment Orientation Test


name: CDISC SDTM Implementation Guide Version 3.2


name: CDISC SDTM Implementation Guide Version 3.3


name: Urinary System Findings Completion Status


name: Human Immunodeficiency Virus Measurement


name: Caregiver Oncology Needs Evaluation Tool


name: Chemokine (C-X3-C Motif) Ligand 1 Measurement


name: Erythrocyte Inclusion Bodies Measurement


name: Stereotactic Accelerated Partial Breast Irradiation


name: Montreal Cognitive Assessment Abstraction Test


name: Adjacent Tissue Transfer or Rearrangement


name: Mental health screening report:Find:Pt:^Patient:Doc


name: Guidance for percutaneous biopsy of Liver


name: PhenX - complete blood count protocol 220501:-:Pt:^Patient:-:PhenX


name: PhenX - complete blood count protocol 220501


name: {1 (0.1 ML) (diazepam 100 MG/ML Nasal Spray [Valtoco]) } Pack [Valtoco 10 MG Dose Kit]


name: {2 (0.1 ML) (diazepam 100 MG/ML Nasal Spray [Valtoco]) } Pack [Valtoco 20 MG Dose Kit]


name: Somatic symptom disorder score:Score:Pt:^Patient:Qn


name: Somatic symptom disorder screening report:Find:Pt:^Patient:Doc


name: Somatic symptom disorder screening report


name: Appointment of legal guardian:Find:Pt:^Patient:Nom


name: ADHD question consistency score:Score:Pt:^Patient:Qn


name: Megalencephaly Cutis Marmorata Telangiectatica Congenita (test kit)


name: Measured weight loss (observable entity)


name: Growth hormone receptor antagonist (disposition)


name: Accessibility of home entrance:Find:Pt:^Patient:Nom


name: Accessibility of home interior:Find:Pt:^Patient:Nom


name: Non-specific active suicidal thoughts:Find:Lifetime:^Patient:Ord


name: WellRx Questionnaire - revised:-:Pt:^Patient:-:WellRx


name: CD19 blasts/100 blasts in blood (lab test)


name: CT Guidance for injection of Joint space


name: CT Guidance for drainage and placement of drainage catheter of appendix


name: MR Guidance for stereotactic biopsy of Brain


name: Substance with acetylcholinesterase reactivator mechanism of action (substance)


name: Product containing vasopressin receptor agonist (product)


name: Vasopressin receptor agonist (disposition)


name: Product containing smoothened receptor agonist (product)


name: Smoothened receptor agonist (disposition)


name: Substance with sodium-hydrogen exchanger isoform 3 transporter inhibitor mechanism of action (substance)


name: Guidance for kyphoplasty of Lumbar spine


name: ADHD hyperactive symptoms severity:Imp:Pt:^Patient:Ord


name: ADHD inattentive symptoms severity:Imp:Pt:^Patient:Ord


name: Advance directive document format:Find:Pt:^Patient:Nom


name: Wish to be dead:Find:Lifetime:^Patient:Ord


name: CT Guidance for drainage and placement of drainage catheter of pancreas


name: CD127 blasts/100 blasts in blood (lab test)


name: Drug classes of medications taken:Type:RptPeriod:^Patient:Nom:CMS Assessment


name: Genetic risk score for coronary heart disease:Score:Lifetime:^Patient:Qn


name: Home accessibility modification date:Date:Pt:^Patient:Qn


name: CT Guidance for drainage and placement of drainage catheter of subphrenic space


name: Dermatan sulfate & heparan sulfate & keratan sulfate panel


name: Dermatan sulfate & heparan sulfate & keratan sulfate panel:-:Pt:Ser/Plas:-


name: little c Ag^during infancy:PrThr:Pt:RBC:Ord


name: HEDIS 2020 Value Set - Mammography:-:Pt:^Patient:-


name: Total parenteral nutrition agent (substance)


name: Bone age assessment - Tanner-Whitehouse (TW2) associated observations panel:-:Pt:^Patient:-


name: Comparison with previous results:Find:Pt:^Patient:Doc


name: PhenX - bone age protocol 220301:-:Pt:^Patient:-:PhenX


name: Body disposition facility name:ID:Pt:Facility:Nom


name: CD11c+CD19+ cells/100 cells in bone marrow


name: cytoplasmic CD22 blasts/100 blasts in blood


name: cytoplasmic CD13 blasts/100 blasts in blood


name: Sodium-hydrogen exchanger isoform 3 transporter inhibitor (disposition)


name: {28 (tolvaptan 15 MG Oral Tablet [Jynarque]) / 28 (tolvaptan 30 MG Oral Tablet [Jynarque]) } Pack [Jynarque 30/15 Carton]


name: {56 (tolvaptan 15 MG Oral Tablet [Jynarque]) } Pack [Jynarque 15/15 Carton]


name: CD11c+CD19+ cells/100 cells in cerebral spinal fluid


name: E Ag^post hematopoietic stem cell transplant:PrThr:Pt:RBC:Ord


name: little e Ag^post hematopoietic stem cell transplant:PrThr:Pt:RBC:Ord


name: Substance use disorder screening report:Find:Pt:^Patient:Doc


name: Cause of sick feeling:Find:Pt:^Patient:Nom


name: CD11c+CD19+ cells/100 cells in body fluid


name: CD11c+CD19+ cells/100 cells in tissue (lab test)


name: CD123 blasts/100 blasts in blood (lab test)


name: Best thing about your day:Find:Pt:^Patient:Nom


name: Body disposition facility address:Addr:Pt:Facility:Nom


name: Bone age assessment - Tanner-Whitehouse (TW2) associated observations panel


name: Date and time of obstetric delivery:TmStp:Pt:^Patient:Qn


name: Date of most lethal suicide attempt:Date:Pt:^Patient:Qn


name: Date of most recent suicide attempt:Date:Pt:^Patient:Qn


name: CD14 blasts/100 blasts in blood (lab test)


name: CD16 blasts/100 blasts in blood (lab test)


name: CD1a blasts/100 blasts in blood (lab test)


name: Central alpha-2 adrenergic receptor agonist (disposition)


name: Substance with central alpha-2 adrenergic receptor agonist mechanism of action (substance)


name: little c Ag^post hematopoietic stem cell transplant:PrThr:Pt:RBC:Ord


name: C Ag^post hematopoietic stem cell transplant:PrThr:Pt:RBC:Ord


name: C Ag^post transfusion reaction:PrThr:Pt:RBC:Ord


name: little c Ag^post transfusion reaction:PrThr:Pt:RBC:Ord


name: DPYD gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: little e Ag^during infancy:PrThr:Pt:RBC:Ord


name: E Ag^post transfusion reaction:PrThr:Pt:RBC:Ord


name: little e Ag^post transfusion reaction:PrThr:Pt:RBC:Ord


name: CT Guidance for drainage and placement of drainage catheter of abdomen


name: CT Guidance for drainage and placement of drainage catheter of anus


name: CT Guidance for drainage and placement of drainage catheter of biliary ducts and gallbladder


name: CT Guidance for drainage and placement of drainage catheter of chest


name: CT Guidance for drainage and placement of drainage catheter of gallbladder


name: CT Guidance for drainage and placement of drainage catheter of kidney


name: CT Guidance for drainage and placement of drainage catheter of liver


name: CT Guidance for drainage and placement of drainage catheter of pelvis


name: CT Guidance for drainage and placement of drainage catheter of retroperitoneum


name: CT Guidance for exchange of nephrostomy tube of Kidney


name: CT guidance for fluid aspiration of breast


name: CT guidance for fluid aspiration of cervical spine intervertebral disc


name: CT guidance for fluid aspiration of chest


name: CT guidance for fluid aspiration of liver


name: CT guidance for fluid aspiration of lung


name: CT guidance for fluid aspiration of neck


name: CT guidance for fluid aspiration of pancreas


name: CT guidance for fluid aspiration of pleural space


name: CT Guidance for injection of Cervical spine Intervertebral disc


name: CT Guidance for localization of placenta of Uterus


name: CT guidance for needle localization of breast


name: CT guidance for needle localization of cervical spine


name: CT Guidance for needle localization of Lumbar spine


name: CT Guidance for needle localization of Thoracic spine


name: CT Guidance for percutaneous replacement of drainage tube of Abdomen


name: CT Guidance for percutaneous replacement of drainage tube of Pelvis


name: CT Guidance for percutaneous vertebroplasty of Lumbar spine


name: CT Guidance for percutaneous vertebroplasty of Thoracic spine


name: CT Guidance for placement of nephrostomy tube in Kidney


name: cytoplasmic CD179a blasts/100 blasts in blood


name: Guidance for drainage and placement of chest tube of Pleural space


name: Guidance for injection of Spine epidural space


name: Guidance for injection of Temporomandibular joint


name: Guidance for kyphoplasty of Thoracic spine


name: Guidance for percutaneous biopsy of Kidney


name: HEDIS 2020 Value Set - Urine Protein Tests


name: HEDIS 2020 Value Set - Urine Protein Tests:-:Pt:^Patient:-


name: Home accessibility evaluation status:Find:Pt:^Patient:Nom


name: Home accessibility modification panel:-:Pt:^Patient:-


name: Home accessibility modification responsible party:Find:Pt:^Patient:Nom


name: Home accessibility modification responsible party


name: HEDIS 2020 Value Set - BMI:-:Pt:^Patient:-


name: HEDIS 2020 Value Set - BMI percentile:-:Pt:^Patient:-


name: HEDIS 2020 Value Set - CT Colonography:-:Pt:^Patient:-


name: HEDIS 2020 Value Set - Diastolic Blood Pressure:-:Pt:^Patient:-


name: HEDIS 2020 Value Set - Diastolic Blood Pressure


name: HEDIS 2020 Value Set - Systolic Blood Pressure:-:Pt:^Patient:-


name: HEDIS 2020 Value Set - Systolic Blood Pressure


name: Setting of exposure to environmental or occupational hazard:Type:Pt:^Patient:Nom


name: Lifetime risk for developing coronary heart disease based on genetic risk score:Likelihood:Lifetime:^Patient:Ord


name: Somatic symptom disorder severity:Imp:Pt:^Patient:Ord


name: Substance use disorder question consistency score:Score:Pt:^Patient:Qn


name: Substance use disorder score:Score:Pt:^Patient:Qn


name: Medical records in response to authorization denial


name: Medical records in response to authorization denial:Find:Pt:^Patient:Doc


name: Substance use disorder severity:Imp:Pt:^Patient:Ord


name: Insertion of composite restoration using strip crown


name: Healthy Eating Index 2015 (assessment scale)


name: Monocyte chemotactic protein-2 measurement


name: Discharge/discontinuation of the episode of care documented in the medical record (M1009)


name: Discharge/discontinuation of the episode of care documented in the medical record (M1012)


name: Discharge/discontinuation of the episode of care documented in the medical record (M1014)


name: Discharge/discontinuation of the episode of care documented in the medical record (M1011)


name: Discharge/discontinuation of the episode of care documented in the medical record (M1010)


name: Discharge/discontinuation of the episode of care documented in the medical record (M1013)


name: Discharge/discontinuation of the episode of care documented in the medical record (M1015)


name: Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care (M1112)


name: Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care (M1107)


name: Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care (M1122)


name: The start of an episode of care documented in the medical record (M1135)


name: The start of an episode of care documented in the medical record (M1111)


name: Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care (M1137)


name: Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care (M1117)


name: Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care (M1127)


name: The start of an episode of care documented in the medical record (M1121)


name: The start of an episode of care documented in the medical record (M1106)


name: The start of an episode of care documented in the medical record (M1136)


name: The start of an episode of care documented in the medical record (M1116)


name: Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care (M1131)


name: The start of an episode of care documented in the medical record (M1126)


name: Was Menopausal Hormone Therapy Ever Used Question


name: Was another Form of Birth Control Ever Used Question


name: Have Oral Contraceptives Ever Been Taken Question


name: Date and Method of Initial Pathologic Diagnosis


name: Date of Tumor Progression After Initial Treatment


name: Date of Tumor Reoccurrence After Initial Treatment


name: Did the Individual have Multiple Known Primary Tumors at Initial Melanoma Diagnosis Question


name: What is the First Course Treatment Completion Measure of Success of Outcome Question


name: Initial Pathologic Diagnosis Method Question


name: Did a New Event Occur After Initial Treatment Question


name: Number of Days from Date of Initial Pathologic Diagnosis to Date of Additional Surgery for New Tumor Event Loco-Regional


name: Number of Days from Date of Initial Pathologic Diagnosis to Date of Additional Surgery for New Tumor Event Metastasis


name: Number of Days from Date of Initial Pathologic Diagnosis to Date of Tumor Progression after Initial Treatment


name: Number of Days from Date of Initial Pathologic Diagnosis to Date of Tumor Reoccurrence After Initial Treatment


name: Number of Discontiguous Lesions (New Tumor Event)


name: Number of Known Primaries at the Time of Initial Melanoma Diagnosis


name: Number of Other Lymph Nodes Positive for Tumor by H&E


name: Number of Other Lymph Nodes Positive for Tumor by IHC staining only


name: Number of Para-aortic Lymph Nodes Examined


name: Number of Para-aortic Lymph Nodes Positive for Tumor by H&E


name: Number of Para-aortic Lymph Nodes Positive for Tumor by IHC Staining Only


name: Number of Pelvic Lymph Nodes Positive for Tumor by H&E


name: Number of Pelvic Lymph Nodes Positive for Tumor by IHC staining only


name: Preoperative Karnofsky Performance Status Question


name: Preoperative ECOG - Performance Status Question


name: Were Immunophenotype and Cytochemistry Analyses Performed on Bone Marrow Aspirate Question


name: Number of Primary Tumors in this Location


name: Was Adjuvant Post-operative Radiation Therapy Administered Question


name: Was Adjuvant Post-Operative Chemotherapy Administered Question


name: Was Adjuvant Post-Operative Hormone Therapy Administered Question


name: Was Adjuvant Post-Operative Immunological Therapy Administered Question


name: Was Adjuvant Post-Operative Pharmaceutical Therapy Administered Question


name: Was Adjuvant Post-Operative Targeted Molecular Therapy Administered Question


name: Brimonidine Tartrate Nanoemulsion OCU-300


name: What is the Other Performance Status Scale: Timing Question


name: Performance Status Scale: Timing Question


name: Did the Physician Diagnose Diabetes Question


name: Is there a History of Colorectal Cancer Question


name: What is the Follow-Up Form Completion Outcome Measure of Success Question


name: Specify Other Performance Status Scale: Timing Question


name: Progression of Disease at Recurrence Question


name: No Evidence of Disease at Follow-Up Question


name: What is the Procedure Type for New Tumor Event Question


name: Other Procedure Type for New Tumor Event Question


name: What is the Status of the Residual Tumor After Surgery for New Tumor Event Question


name: Was Additional Treatment Administered for New Tumor Event Question


name: Were Immunophenotype and Cytochemistry Analyses Performed on Peripheral Blood Samples Question


name: Bone Marrow Aspirate Immunophenotype & Cytochemistry Question


name: Peripheral Blood Immunophenotype & Cytochemistry Question


name: Well-Differentiated or De-Differentiated New Tumor Question


name: Diagnostic Evidence of Recurrence/Relapse Question


name: Biopsy with Histologic Confirmation Question


name: Related to Head and Neck Cancer Question


name: Related to Acute Myeloid Leukemia Question


name: Type of New Melanoma Related Tumor Event Question


name: Did the Individual use Smokeless Tobacco Use at Diagnosis Question


name: Regular Smokeless Tobacco Use for Six Weeks or More Question


name: Average Daily Use Smokeless Tobacco after Use for Six Weeks Question


name: Age When Quit using Smokeless Tobacco after Regular Use Question


name: What is the Definitive Therapy Method Question


name: Was Evidence of Disease Present after Completion of Therapy


name: Was Tumor Progression Present After Initial Treatment Question


name: Was Tumor Reoccurrence Present After Initial Treatment Question


name: Were Local Anesthesia Agents Administered Question


name: Were Routine Cytogenetics Completed Question


name: No Pathologic Evidence of Distant Metastasis Question


name: Premenopausal Greater than 6 months since LMP and no Prior Bilateral Oophorectomy and Not on Estrogen Replacement Question


name: Perimenopausal 6 to 12 Months Since LMP Question


name: Postmenopausal with no Prior Oophorectomy Status Question


name: Primary Site of New Non-Melanoma Tumor Event Question


name: Histological Type of New Non-Melanoma Tumor Event Question


name: Site of New Distant Metastasis Tumor Event Question


name: Specify Molecular Abnormalities in Study


name: Days to Absolute Neutrophil Count Greater than 1000 per Microliter


name: Days to Platelet Count Greater than 100,000 per Microliter


name: del(10q23)/PTEN Gene Locus Deletion Analysis


name: del(10q23)/PTEN Gene Locus Deletion Analysis Method


name: EGFR Amplification Analysis Testing Method


name: Percent Blasts in Peripheral Blood at Diagnosis


name: Classified by World Health Organization Only Question


name: Complete Blood Count from Clinical Peripheral Blood (Within 24 Hours of Banking) Question


name: Specify Other ERBB2 Non-Exon 20 Mutation


name: MGMT Promoter Methylation Testing Method


name: Is Another BRAF Mutation Present Question


name: Is Another Non-Exon 20 ERBB2 Mutation Present Question


name: Is Another KIT Mutation Present Question


name: Is Another NRAS Mutation Present Question


name: Specify Molecular Abnormality Analysis Method


name: SDH Complex Mutation Analysis Testing Method


name: Did Caregiving Responsibilities Make it Difficult to Work the Required Number of Job Hours Question


name: Did Caregiving Responsibilities Make it Difficult to Get Going Easily at Beginning of Workday Question


name: Did Caregiving Responsibilities Make it Difficult to Start Job on Arrival at Work Question


name: Did Caregiving Responsibilities Make it Difficult to do Work Without Stopping For Breaks or Rests Question


name: Did Caregiving Responsibilities Make it Difficult to Stick to Job Routine or Schedule Question


name: Have Difficulty with Sitting, Standing, or Staying in One Position Longer than 15 Minutes While Working Due to Caregiving Responsibilities Question


name: Have Difficulty Repeating Same Motions Repeatedly While Working Due to Caregiving Responsibilities Question


name: Did Caregiving Responsibilities Make it Difficult to Keep Mind on Work Question


name: Did Caregiving Responsibilities Make it Difficult to Do Work Carefully Question


name: Did Caregiving Responsibilities Make it Difficult to Think Clearly When Working Question


name: Did Caregiving Responsibilities Make it Difficult to Concentrate on Work Question


name: Did Caregiving Responsibilities Make it Difficult to Work Without Losing Train of Thought Question


name: Did Caregiving Responsibilities Make it Difficult to Easily Read or Use Eyes When Working Question


name: Did Caregiving Responsibilities Make it Difficult to Speak With People In-Person, in Meetings, or Phone When Working Question


name: Did Caregiving Responsibilities Make it Difficult to Control Temper Around People When Working Question


name: Did Caregiving Responsibilities Make it Difficult to Help Other People to Get Work Done Question


name: Did Caregiving Responsibilities Make it Difficult to Listen Well to New Information Given at Work Question


name: Did Caregiving Responsibilities Make it Difficult to Control Feelings of Sadness or Grief When Working Question


name: Did Caregiving Responsibilities Make it Difficult to Handle Workload Question


name: Did Caregiving Responsibilities Make it Difficult to Work Fast Enough Question


name: Did Caregiving Responsibilities Make it Difficult to Finish Work on Time Question


name: Did Caregiving Responsibilities Make it Difficult to Do Work Without Making Mistakes Question


name: Did Caregiving Responsibilities Make it Difficult to Feel You've Done What You're Capable of Doing Question


name: Have Difficulty Doing Usual Household Chore or Activity Because of Caregiving Responsibilities Question


name: Someone There for Suggestions About How to Deal with Personal Problem Question


name: Someone There to Love and Make You Feel Wanted Question


name: Someone There to Get Together for Relaxation Question


name: Someone There to Help With Daily Chores if Sick Question


name: Someone There to Perform Caregiving Responsibilities When You Cannot Question


name: Someone There for Questions or Concerns About Caregiving Question


name: Being Able to Provide Assistance as Caregiver is Emotionally Rewarding for Me Question


name: Being Able to Provide Assistance as Caregiver is Spiritually Rewarding for Me Question


name: Being Able to Provide Assistance as Caregiver Helps Me Feel in Control of Situation Question


name: Being Able to Provide Assistance as Caregiver is Important to Me Question


name: Being Able to Provide Assistance as Caregiver is My Duty as Responsible Adult Question


name: Currently Paying Someone to Assist with Caregiving Question


name: Plan to Take Leave of Absence From Work Over Next Year Because of Caregiving Question


name: CO2 Level at Organ Excision Time Question


name: Was Interferon Gamma Treatment Administered Prior to Specimen Resection Question


name: Was Interferon Gamma Treatment Administered 90 Days Prior to Specimen Resection Question


name: Method of Left Lymph Node Dissection Question


name: Method of Right Lymph Node Dissection Question


name: Other Notable Events During Surgery Question


name: Description of Epochs of O2 Desaturation Less than 92% Greater than 5 Minutes Prior to Organ Excision Question


name: Intraoperative Blood Product Administration Question


name: Were Other Medications Administered During Surgery Question


name: Antibiotics Administered During Surgery Question


name: Were Steroids Administered During Surgery Question


name: Was Insulin Administered During Surgery Question


name: Other Medications Administered During Surgery Prior to Tumor Tissue Removal Question


name: Surgery Information Indicate If any of the Following Medications were Administered During Surgery


name: Was Inhalation Anesthesia Administered Question


name: Specify Other Muscle Relaxants Administered Question


name: Were IV Muscle Relaxants Administered Question


name: Specify Other Narcotics or Opiates Administered Question


name: Was Regional Anesthesia Administered Question


name: Were Other Preoperative IV Medications Administered Question


name: Were Preoperative IV Antacids Administered Question


name: Were Preoperative IV Antiemetics Administered Question


name: Were Preoperative IV Opiates Administered Question


name: Specify Other Preoperative IV Sedation Administered Question


name: Was Preoperative IV Sedation Administered Question


name: Highest Grade Pancreatic Intraepithelial Neoplasia Question


name: Which Pulmonary Function Tests Were Performed Question


name: Pathologic Findings in Non-Neoplastic Kidney Question


name: Prognostic Features Used for Tumor Prognosis Question


name: Renal Vein or Vena Cava Thrombosis or Other Coagulopathies Question


name: HPV Status by in situ Hybridization Question


name: CPTAC Acute Myeloid Leukemia Baseline Form


name: Prepare and Give Medicines, Fluids, Nutrition Intravenously Question


name: Prepare and Give Medicine as Shot in Muscle or Under Skin Question


name: Prepare and Give Medications by Mouth Question


name: Prepare and Give Catheter Flushes Question


name: Change Dressing on Your Child's Catheter and Change Catheter Cap Question


name: Manage Child's Side Effects of Cancer or its Treatment Question


name: Keep Your Child Comfortable and Without Pain Question


name: Manage Other Childhood Illnesses for Your Child with Cancer Question


name: Manage Unexpected Events Related to Your Child's Illness Question


name: Additional Household Tasks Related to Your Child's Illness Question


name: Coordinate, Arrange, and Manage Child's Medical Services Question


name: Travel to and From Hospital for Medical Care Question


name: How Much Time Spent at Hospital for Appointments Question


name: How Much Effort or Difficulty for Time Spent at Hospital for Appointments Question


name: Provide Emotional Support for Your Child with Cancer Question


name: Provide Emotional Support for Other Children in the Family Question


name: Provide Emotional Support for Extended Family Question


name: Provide Support for Spouse or Partner Question


name: Meet Your Own Emotional Support Needs Question


name: Comfort Your Child Through Pain of Cancer and its Treatment Question


name: Take Care of Discipline and/or Behavior Problems of Child with Cancer Question


name: Take Care of Finances, Bills, and Forms Related to Child's Illness Question


name: Plan Activities for Your Child with Cancer Around Treatment and Illness Question


name: Plan Activities for Your Family Around Treatment and Illness Question


name: Get Child Care or Babysitting Help for Your Ill Child Question


name: Get Child Care or Babysitting for Siblings of Ill Child Question


name: Communicate Information About Cancer to Schools, Day Care, Babysitters, Extended Family, and Friends Question


name: Watch for and Report Your Child's Physical Symptoms and Medical Condition to Medical Team Question


name: Get Information on Your Child's Illness and Treatment Question


name: Anything Else You Wish to Tell About Taking Care of Your Child with Cancer Question


name: CPTAC Uterine Corpus Endometrial Carcinoma Baseline Form


name: CPTAC Lung Squamous Cell Carcinoma and Lung Adenocarcinoma Baseline Form


name: CPTAC Clear Cell Renal Cell Carcinoma Baseline Form


name: CPTAC Head and Neck Squamous Cell Carcinoma Baseline Form


name: CPTAC Glioblastoma Multiforme Baseline Form


name: Regimen Used to Treat Malignant Thymus Neoplasm


name: Regimen Used to Treat Malignant Anal Neoplasm


name: Regimen Used to Treat Chronic Myeloid Leukemia


name: Regimen Used to Treat Merkel Cell Carcinoma


name: Regimen Used to Treat Myelodysplastic Syndromes


name: Regimen Used to Treat Hepatobiliary Cancer


name: Regimen Used to Treat Plasma Cell Neoplasm


name: Regimen Used to Treat Primary Amyloidosis


name: Regimen Used to Treat Malignant Soft Tissue Neoplasm


name: Additional Anesthesia Agents Used Question


name: Were IV Narcotic/Opiate Agents Administered Question


name: Radium Ra 224-labeled Calcium Carbonate Microparticles


name: Was EGFR Amplification Assessed Question


name: Validated Hemophilia Regimen Treatment Adherence Scale - On-Demand


name: Validated Hemophilia Regimen Treatment Adherence Scale - Prophylaxis


name: Indeterminate Macroscopic Satellite Nodule Question


name: Other Site of New Distant Metastasis Tumor Event Question


name: Specify Site of Other New Tumor Event Question


name: Other Site of New Primary Melanoma Question


name: Was the Individual Exposed to Second-Hand Smoke Question


name: Specify Other Inhalation Anesthesia Agents Question


name: Specify Other Preoperative IV Anesthesia Administered Question


name: Was Molecular Analysis Performed Question


name: Response Evaluation Criteria In Lymphoma 2017


name: Indeterminate or Unknown Menopause Status Question


name: Were Additional Molecular Studies Performed Question


name: Was 10q23/PTEN Locus Deletion Analysis Performed Question


name: Was 1p/19q Deletion Analysis Performed Question


name: Was ATRX Mutation Analysis Performed Question


name: Was BRAF Mutation Analysis Performed Question


name: Was ERBB2 Mutation Analysis Performed Question


name: Was IDH Family Mutation Analysis Performed Question


name: Was Immunohistochemical Testing Performed Question


name: Was Additional Immunohistochemical Testing Performed Question


name: Was Additional Mutation Analysis Performed Question


name: Was KIT Mutation Analysis Performed Question


name: Was KRAS Mutation Analysis Performed Question


name: Was Lymph Node Dissection Performed Question


name: Was MET Mutation Analysis Performed Question


name: Was MGMT Promoter Methylation Testing Performed Question


name: Was NF1 Mutation Analysis Performed Question


name: Was NRAS Mutation Analysis Performed Question


name: Was PTEN Mutation Analysis Performed Question


name: Was SDH Complex Mutation Analysis Performed Question


name: Was TP53 Mutation Analysis Performed Question


name: Was Fluorescence In Situ Hybridization Performed Question


name: Regimen Used to Treat or Prevent Graft Rejection


name: Autologous Stem Cell Transplant Recipient


name: Allogeneic Stem Cell Transplant Recipient


name: ECOG Performance Status not Evaluated, not Provided or Available Question


name: Unknown ECOG Performance Status Question


name: Modified Severity Weighted Assessment Tool


name: First Visit Year with All Necessary Components to Determine


name: Specify Site If Distant Metastasis Submitted Question


name: Specify New Tumor Metastasis Site Question


name: How Many Places Lived with Child Question


name: Struggle with Rent or Mortgage Due to Financial Difficulties Question


name: Live with Others Due to Financial Difficulties Question


name: Lack of Reliable Transportation Keeps from Appointments, Meetings, Work, or Daily Living Question


name: Utility Company Threatened to Shut Off Services for not Paying Bills Question


name: Utility Company Shut Off Services for not Paying Bills Question


name: Days Home Not Heated or Cooled Because Bills Not Paid Question


name: Used Cooking Stove to Heat Home Because Bills Not Paid Question


name: Telephone Service Disconnected Due to Bill Not Paid Question


name: Worried Food Would Run Out Before Get Money to Buy More Question


name: Food Bought Didn't Last and Didn't Have Money to Get More Question


name: If Lose Current Income Sources and Live Off Savings, How Long Could Continue to Live at Current Address and Standard of Living Question


name: Family Received Food from Food Pantry or Soup Kitchen Question


name: Family Received Energy Assistance Question


name: Family Received Disability Benefits Question


name: Family Received Low-Income or Subsidized Housing Question


name: Family Received Free or Subsidized School Lunch Question


name: Family Received Employment Insurance Question


name: Family Received Canada Child Benefit Question


name: Family Received Disability Tax Credit Question


name: Specify Number of Lymph Nodes Positive for Tumor by IHC Staining Only Question


name: Specify Number of Lymph Nodes Positive for Tumor by H&E Question


name: International Myeloma Working Group Minimal Residual Disease Criteria


name: International Myeloma Working Group Standard Response Criteria


name: Outcome Measure of Success at Completion of Initial Treatment Course Not Applicable Question


name: Outcome Measure of Success at Completion of Initial Treatment Unknown Question


name: Can't Hear Yourself Think at Home Question


name: Have a Regular Morning Routine in Our Home Question


name: Able to Adapt When Changes Occur Question


name: Can Deal with Whatever Comes my Way Question


name: Try to See Humorous Side of Things When Faced with Problems Question


name: Having to Cope with Stress can Make me Stronger Question


name: Tend to Bounce Back After Illness, Injury, or Other Hardships Question


name: Can Achieve my Goals, Even if There are Obstacles Question


name: Not Easily Discouraged by Failure Question


name: Think of Myself as a Strong Person When Dealing with Life's Challenges and Difficulties Question


name: Able to Handle Unpleasant or Painful Feelings Question


name: Treated with Less Courtesy or Respect than Other People Question


name: Receive Poorer Service Than Other People at Restaurant or Stores Question


name: People Act as if They Think You are Not Smart Question


name: People Act as if They are Afraid of You Question


name: Specify Other Non-Neoplastic Finding Question


name: Regimen Used to Treat Malignant Bone Marrow Neoplasm


name: Retrograde Selective Washing of Upper Tract


name: Regimen Used to Treat Malignant Intestinal Neoplasm


name: Was a New Tumor Event Present After Initial Treatment Question


name: Regimen Used to Treat Malignant Fallopian Tube Neoplasm


name: Regimen Used to Treat Malignant Peritoneal Neoplasm


name: Lymphedema Symptom Intensity and Distress Survey - Arm


name: Regimen Used to Treat Malignant Germ Cell Tumor


name: Regimen Used to Treat Malignant Reproductive Endocrine Neoplasm


name: Have Difficulty Moving Arm Side to Side Question


name: Have Difficulty Raising Arm Above Head Question


name: Have Lack of Confidence in Self Question


name: Have Lack of Confidence in Insurance Provider Question


name: Have Concerns About How You Look Question


name: Feel Misunderstood by Spouse or Significant Other Question


name: Feel Frustration with Insurance Company Question


name: Have Loss of Confidence in Body Question


name: Partner Has Lack of Interest in Sex Question


name: Have Inability to Complete Hobbies or Leisure Activities Question


name: Consistently Decreased Social Activities Question


name: Have Decrease in Sexual Activity Question


name: Symptoms Intensity and Distress Likert Scale


name: Fluorouracil Continuous Infusion Regimen


name: Methotrexate Intra-Cerebrospinal Fluid Regimen


name: Intralesional Interferon Alfa-2b Regimen


name: Talimogene Laherparepvec Intralesional Regimen


name: Rituximab and Hyaluronidase Human Regimen


name: Unknown Supratentorial Localization Question


name: Was an IDH Family Mutation Identified Question


name: Was an ATRX Mutation Identified Question


name: Was an EGFR Amplification Identified Question


name: Needed Medical Care or Prescription Medicine but Unable to Afford it Question


name: Who Needed Medical Care but Family Unable to Afford it Question


name: Who Needed Prescription Medicine but Family Unable to Afford it Question


name: Specify Another Form of Birth Control that was Used Question


name: Does the Individual have Hypertension Question


name: MLH1 Gene Promoter Hypermethylation Status


name: Was Additional Surgery for New Loco-Regional Tumor Event Performed Question


name: Was Additional Surgery for New Metastatic Tumor Event Performed Question


name: Date of Additional Surgery for New Tumor Event: Loco-Regional Question


name: Date of Additional Surgery for New Tumor Event: Metastatic Question


name: Never Quit using Smokeless Tobacco after Regular Use Question


name: Antithymocyte Globulin Rabbit/Tacrolimus Regimen


name: Horse Antithymocyte Globulin/Tacrolimus Regimen


name: Rabbit Anti-thymocyte Globulin/Prednisone/Tacrolimus Regimen


name: Equine Anti-thymocyte Globulin/Prednisone/Tacrolimus Regimen


name: Dose-adjusted R-EPOCH Plus High-dose Methotrexate Regimen


name: R-CODOX-M Alternating with R-IVAC Regimen


name: Was ALK Rearrangement Analysis Performed Question


name: Was BRAF Rearrangement Analysis Performed Question


name: Was PDGFRA Mutation Analysis Performed Question


name: Was RET Rearrangement Analysis Performed Question


name: Was ROS1 Rearrangement Analysis Performed Question


name: Was EGFR Mutation Analysis Performed Question


name: Unknown Age When Started using Smokeless Tobacco after Regular Use Question


name: Tissue Expander-Implant Breast Reconstruction


name: Was Radiation Administered as an Additional Treatment for a New Tumor Event Question


name: Was Chemotherapy Administered as an Additional Treatment for a New Tumor Event Question


name: Was Immunotherapy Administered as an Additional Treatment for a New Tumor Event Question


name: Was Hormone Therapy Administered as an Additional Treatment for a New Tumor Event Question


name: Was Targeted Molecular Therapy Administered as an Additional Treatment for a New Tumor Event Question


name: Was Additional Pharmaceutical Treatment for New Tumor Event Administered Question


name: Number of Days from Date of Collection to Date of Last Contact


name: Is Paraneoplastic Syndrome Present Question


name: Was Bone Marrow Transplantation Performed Question


name: Was Radiation Therapy Administered Question


name: Was Pharmacotherapy Administered Question


name: Specify if Other Cytogenetic Analysis Abnormality Type


name: Were Molecular Abnormalities Detected Question


name: Discrete Set Telecommunication URL Data Type


name: Regimen Used to Treat Non-neoplastic Hematologic Disorders


name: Histologic Grade for Other Carcinomas Question


name: Macroscopic Satellite Nodule Not Identified Question


name: Are Tumor Infiltrating Lymphocytes Present Question


name: Is Extranodal Tumor Involvement Present Question


name: Are Sarcomatoid Features Present Question


name: Test of Word Reading Efficiency, Second Edition


name: Oral Mechanism/Cranial Nerve Examination for Young Children


name: Head and Neck Survivorship Tool: Assessment and Recommendations


name: Computed Spanish/Hispanic Ethnicity Code


name: CDISC Protocol Study Population Attribute Terminology


name: CDISC SDTM Laboratory Analytical Method Calculation Formula Terminology


name: CDISC SDTM Model Version ResponseTerminology


name: CDISC SDTM Implementation Guide Version Response Terminology


name: CDISC Therapeutic Area User Guide Response Terminology


name: CDISC SDTM FDA Technical Specification Response Terminology


name: CDISC SEND Body Irradiation Model Response Terminology


name: CDISC SEND Rad/Nuc Targeted Injury Model Response Terminology


name: CDISC SEND Chemical Challenge Agent Name Response Terminology


name: CDISC SEND Genus and Species Response Terminology


name: Beta-lactamase Positive Bacteria Measurement


name: Beta-lactamase Negative Bacteria Measurement


name: Non-Cogstate Baseline and Follow-up Measures


name: Automated Video-Assisted Smoking Treatment


name: Evidence of Malignant Disease Description


name: CDISC Diabetes Therapeutic Area User Guide Version 1.0 - Supplement for ADaM


name: Robot-Assisted Salvage Pelvic Lymph Node Dissection


name: Robot-assisted Salvage Pelvic Mass Resection


name: Kappa Light Chain to Lambda Light Chain Ratio Measurement


name: Cytochrome P450 2C9 Activity Measurement


name: Progressive Spermatozoa to Total Spermatozoa Ratio Measurement


name: pH Adjusted for Body Temperature Measurement


name: Thyroid Stimulating Immunoglobulin Actual to Control Ratio Measurement


name: APTT-LA Actual to Control Ratio Measurement


name: Thrombin Time Actual to Control Ratio Measurement


name: APTT-LA Screen to Confirm Percent Difference


name: dRVVT Screen to Confirm Percent Difference


name: Choriogonadotropin Adjusted for Maternal Weight Measurement


name: Neisseria gonorrhoeae, Beta-lactamase Positive Measurement


name: Neisseria gonorrhoeae, Beta-lactamase Negative Measurement


name: Multiple Inert Gas Elimination Technique


name: Natural Log Transformed Observed Area Under the Curve Infinity


name: Natural Log Transformed Area Under the Curve From Dosing to Last Concentration


name: CDISC SDTM Implementation Guide Version 3.1.1


name: CDISC SDTM Implementation Guide Version 3.1.2


name: CDISC SDTM Implementation Guide Version 3.1.2 Amendment 1


name: CDISC SDTM Implementation Guide Version 3.1.3


name: CDISC Chronic Hepatitis C Therapeutic Area User Guide Version 1.0


name: CDISC Diabetic Kidney Disease Therapeutic Area User Guide Version 1.0


name: CDISC Duchenne Muscular Dystrophy Therapeutic Area User Guide Version 1.0


name: CDISC Dyslipidemia Therapeutic Area User Guide Version 1.0


name: CDISC Ebola Therapeutic Area User Guide Version 1.0


name: CDISC Influenza Therapeutic Area User Guide Version 1.1


name: CDISC Influenza Therapeutic Area User Guide Version 1.0


name: CDISC Kidney Transplant Therapeutic Area User Guide Version 1.0


name: CDISC Major Depressive Disorder Therapeutic Area User Guide Version 1.0


name: CDISC Malaria Therapeutic Area User Guide Version 1.0


name: CDISC Prostate Cancer Therapeutic Area User Guide Version 1.0


name: CDISC QT Studies Therapeutic Area User Guide Version 1.0


name: CDISC Rheumatoid Arthritis Therapeutic Area User Guide Version 1.0


name: CDISC Schizophrenia Therapeutic Area User Guide Version 1.1


name: CDISC Schizophrenia Therapeutic Area User Guide Version 1.0


name: CDISC Traumatic Brain Injury Therapeutic Area User Guide Version 1.0


name: CDISC Tuberculosis Therapeutic Area User Guide Version 2.0


name: CDISC Vaccines Therapeutic Area User Guide Version 1.1


name: CDISC Virology Therapeutic Area User Guide Version 2.1


name: CDISC Virology Therapeutic Area User Guide Version 2.0


name: CDISC Alzheimer's Therapeutic Area User Guide Version 1.0


name: CDISC Alzheimer's Therapeutic Area User Guide Version 2.0


name: CDISC Asthma Therapeutic Area User Guide Version 1.0


name: CDISC Breast Cancer Therapeutic Area User Guide Version 1.0


name: CDISC Cardiovascular Studies Therapeutic Area User Guide Version 1.0


name: CDISC Colorectal Cancer Therapeutic Area User Guide Version 1.0


name: CDISC COPD Therapeutic Area User Guide Version 1.0


name: CDISC HIV Therapeutic Area User Guide Version 1.0


name: CDISC Huntington's Disease Therapeutic Area User Guide Version 1.0


name: CDISC Multiple Sclerosis Therapeutic Area User Guide Version 1.0


name: CDISC Pain Therapeutic Area User Guide Version 1.0


name: CDISC Pain Therapeutic Area User Guide Version 1.1


name: CDISC Parkinson's Disease Therapeutic Area User Guide Version 1.0


name: CDISC Polycystic Kidney Disease (PKD) Therapeutic Area User Guide Version 1.0


name: CDISC Post Traumatic Stress Disorder Therapeutic Area User Guide Version 1.0


name: US FDA HIV Technical Specifications Guidance v1.0


name: US FDA Vaccines Technical Specification Guidance v1.0


name: US FDA Clinical Endpoint BE Studies v1.0


name: US FDA Study Data Technical Conformance Guide v4.2.1


name: Expected Onset of Rad/Nuc Targeted Injury


name: Chemical Agent Material Identification Code


name: Total Body Irradiation Plus Bone Marrow Transplant


name: Total Body Irradiation with Bone Marrow Not Irradiated


name: Bio-enhanced Curcumin Extract Formulation


name: CDISC Questionnaire EORTC QLQ-C15-PAL Version 1 Test Name Terminology


name: CDISC Questionnaire EORTC QLQ-C15-PAL Version 1 Test Code Terminology


name: CDISC Questionnaire EORTC QLQ-C30 Version 3 Test Name Terminology


name: CDISC Questionnaire EORTC QLQ-C30 Version 3 Test Code Terminology


name: CDISC Questionnaire T1-DDS Test Name Terminology


name: CDISC Questionnaire T1-DDS Test Code Terminology


name: CDISC Clinical Classification AVPU Test Name Terminology


name: CDISC Clinical Classification AVPU Test Code Terminology


name: CDISC Clinical Classification BPRS 1988 Version Test Name Terminology


name: CDISC Clinical Classification BPRS 1988 Version Test Code Terminology


name: CDISC Clinical Classification E-TRIP Test Name Terminology


name: CDISC Clinical Classification E-TRIP Test Code Terminology


name: EORTC QLQ-C15-PAL Version 1 Questionnaire Question


name: EORTC QLQ-C30 Version 3 Questionnaire Question


name: BPRS 1988 Version Clinical Classification Question


name: European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Paliative Care Version 1.0


name: European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0


name: Diabetes Distress Scale for Adults with Type 1 Diabetes Questionnaire


name: Alert Verbal Painful Unresponsive Scale Clinical Classification


name: Brief Psychiatric Rating Scale 1988 Version Clinical Classification


name: Emory Treatment Resistance Interview for PTSD Clinical Classification


name: EORTC QLQ-C15-PAL Version 1 - Trouble Taking Short Walk Outside


name: EORTC QLQ-C15-PAL Version 1 - Stay in Bed or Chair During the Day


name: EORTC QLQ-C15-PAL Version 1 - Need Help Eating, Dressing, Washing


name: EORTC QLQ-C15-PAL Version 1 - Were You Short of Breath


name: EORTC QLQ-C15-PAL Version 1 - Have You Had Pain


name: EORTC QLQ-C15-PAL Version 1 - Have You Had Trouble Sleeping


name: EORTC QLQ-C15-PAL Version 1 - Have You Lacked Appetite


name: EORTC QLQ-C15-PAL Version 1 - Have You Felt Nauseated


name: EORTC QLQ-C15-PAL Version 1 - Have You Been Constipated


name: EORTC QLQ-C15-PAL Version 1 - Were You Tired


name: EORTC QLQ-C15-PAL Version 1 - Pain Interfere Daily Activities


name: EORTC QLQ-C15-PAL Version 1 - Did You Feel Tense


name: EORTC QLQ-C15-PAL Version 1 - Did You Feel Depressed


name: EORTC QLQ-C15-PAL Version 1 - Rate Your Overall Quality of Life


name: EORTC QLQ-C30 Version 3 - Trouble Doing Strenuous Activities


name: EORTC QLQ-C30 Version 3 - Trouble Taking Long Walk


name: EORTC QLQ-C30 Version 3 - Trouble Taking Short Walk Outside


name: EORTC QLQ-C30 Version 3 - Stay in Bed or Chair During the Day


name: EORTC QLQ-C30 Version 3 - Need Help Eating, Dressing, Washing


name: EORTC QLQ-C30 Version 3 - Limited in Work or Daily Activities


name: EORTC QLQ-C30 Version 3 - Limited Hobbies or Leisure Activities


name: EORTC QLQ-C30 Version 3 - Were You Short of Breath


name: EORTC QLQ-C30 Version 3 - Have You Had Pain


name: EORTC QLQ-C30 Version 3 - Did You Need to Rest


name: EORTC QLQ-C30 Version 3 - Have You Had Trouble Sleeping


name: EORTC QLQ-C30 Version 3 - Have You Felt Weak


name: EORTC QLQ-C30 Version 3 - Have You Lacked Appetite


name: EORTC QLQ-C30 Version 3 - Have You Felt Nauseated


name: EORTC QLQ-C30 Version 3 - Have You Vomited


name: EORTC QLQ-C30 Version 3 - Have You Been Constipated


name: EORTC QLQ-C30 Version 3 - Have You Had Diarrhea


name: EORTC QLQ-C30 Version 3 - Were You Tired


name: EORTC QLQ-C30 Version 3 - Pain Interfere Daily Activities


name: EORTC QLQ-C30 Version 3 - Difficulty Concentrating on Things


name: EORTC QLQ-C30 Version 3 - Did You Feel Tense


name: EORTC QLQ-C30 Version 3 - Did You Feel Irritable


name: EORTC QLQ-C30 Version 3 - Did You Feel Depressed


name: EORTC QLQ-C30 Version 3 - Had Difficulty Remembering Things


name: EORTC QLQ-C30 Version 3 - Condition Interfered Family Life


name: EORTC QLQ-C30 Version 3 - Condition Interfered Social Activities


name: EORTC QLQ-C30 Version 3 - Rate Your Overall Health


name: EORTC QLQ-C30 Version 3 - Rate Your Overall Quality of Life


name: T1-DDS - Not Skilled at Managing Diabetes


name: T1-DDS - I Don't Eat Carefully as I Should


name: T1-DDS - Don't Notice Signs of Hypoglycemia


name: T1-DDS - Discouraged See High Blood Glucose


name: T1-DDS - Family Make Bigger Deal Diabetes


name: T1-DDS - Can't Tell Doctor What on My Mind


name: T1-DDS - Too Much Diabetes Equipment With Me


name: T1-DDS - Family Worry About Hypoglycemia


name: T1-DDS - Don't Check Glucose as I Should


name: T1-DDS - Food and Eating Control My Life


name: T1-DDS - Family Act Like Diabetes Police


name: T1-DDS - Be Perfect With Diabetes Management


name: T1-DDS - Hypoglycemic Event While Driving


name: T1-DDS - Subscale 2: Management Distress


name: T1-DDS - Subscale 3: Hypoglycemia Distress


name: T1-DDS - Subscale 4: Negative Social Perceptions


name: T1-DDS - Subscale 7: Friend/Family Distress


name: BPRS 1988 Version - Emotional Withdrawal


name: BPRS 1988 Version - Conceptual Disorganization


name: BPRS 1988 Version - Mannerisms and Posturing


name: BPRS 1988 Version - Hallucinatory Behavior


name: BPRS 1988 Version - Unusual Thought Content


name: Basic Reversed-Phase Liquid Chromatography


name: pH 7.5 Basic Reversed-Phase Liquid Chromatography


name: 2-Dimensional Reversed-Phase Liquid Chromatography


name: Peripheral T-cell Lymphoma Prognostic Index Score


name: Immobilized Metal Affinity Chromatography with Phosphopeptide Enrichment


name: 14-N/15-N Metabolic Labeling Quantification


name: Selected Reaction Monitoring Quantification


name: Label-free Protein Quantification by LC/MS


name: Label-Free Peptide Level Quantification by LC/MS


name: Label-Free Protein Group Level Quantification by LC/MS


name: Label-Free Raw Feature Quantification by LC/MS


name: Label-Free Gene Level Quantification by LC/MS


name: Allogeneic Bone Marrow Transplantation Recipient


name: Autologous Bone Marrow Transplantation Recipient


name: Musculoskeletal Findings, Connective and Soft Tissue Findings Group Identifier


name: Ophthalmic Examinations Group Identifier


name: Urinary System Findings Group Identifier


name: Cardiovascular System Findings Link Identifier


name: Microbiology Susceptibility Link Identifier


name: Musculoskeletal Findings, Connective and Soft Tissue Findings Link Identifier


name: Reproductive System Findings Link Identifier


name: Microbiology Specimen Link Group Identifier


name: Musculoskeletal Findings, Connective and Soft Tissue Findings Link Group Identifier


name: Reproductive System Findings Link Group Identifier


name: Tumor Identification Link Group Identifier


name: Urinary System Findings Link Group Identifier


name: Cardiovascular System Findings Link Group


name: Cardiovascular System Findings Reference Identifier


name: Functional Tests Sponsor-Defined Identifier


name: Microbiology Specimen Focus of Study-Specific Interest


name: Microbiology Specimen Measurement, Test or Examination Detail


name: Microbiology Susceptibility Non-host Organism Identifier


name: Microbiology Susceptibility Measurement, Test or Examination Detail


name: Microbiology Susceptibility Modified Reported Name


name: Microbiology Susceptibility External File Path


name: Microbiology Susceptibility Analysis Method


name: Microbiology Susceptibility Collected Duration


name: Musculoskeletal Findings, Connective and Soft Tissue Findings Sponsor-Defined Identifier


name: Nervous System Sponsor-Defined Identifier


name: Urinary System Findings Sponsor-Defined Identifier


name: Musculoskeletal Findings, Connective and Soft Tissue Findings Elapsed Time


name: Reproductive System Findings Elapsed Time


name: Musculoskeletal Findings, Connective and Soft Tissue Findings Reference Identifier


name: Respiratory System Findings Reference Identifier


name: Urinary System Findings Reference Identifier


name: Musculoskeletal Findings, Connective and Soft Tissue Findings Time Point Reference


name: Ophthalmic Examinations Time Point Reference


name: Reproductive System Findings Time Point Reference


name: Proton Multiple Quantum Coherence Magnetic Resonance Spectroscopic Imaging


name: Ophthalmic Examinations External File Path


name: Urinary System Findings Time Point Reference


name: Musculoskeletal Findings, Connective and Soft Tissue Findings Completion Status


name: Nervous System Findings Completion Status


name: Ophthalmic Examinations Completion Status


name: Ophthalmic Examinations Normal or Reference Range Indicator


name: Microbiology Susceptibility Normal or Reference Range Indicator


name: Microbiology Susceptibility Specimen Type


name: Microbiology Susceptibility Agent Concentration Unit


name: Spectral Domain-Optical Coherence Tomography


name: Was In Situ Hybridization Performed Question


name: Protein Expression Analysis by Immunohistochemistry


name: Bone Marrow Differential Count within 24 Hours of Banking


name: Navigated Transcranial Magnetic Stimulation


name: Whole Abdominopelvic Intensity-Modulated Radiotherapy


name: Behavioral Activation Intervention to Smoking Cessation and to Post-Cessation Weight Gain


name: Principal Statistical Analysis Plan Version


name: Statistical Analysis Plan Document Version


name: Specify Other Preoperative IV Antacids Administered Question


name: Specify Other Preoperative IV Antiemetics Administered Question


name: Revised International Prognostic Scoring System


name: Specify Other Spinal/Epidural Anesthesia Agents Administered Question


name: Montreal Cognitive Assessment Visuospatial/Executive Test


name: Montreal Cognitive Assessment Attention - Digits Test


name: Montreal Cognitive Assessment Attention - Letters Test


name: Montreal Cognitive Assessment Attention - Subtraction Test


name: Montreal Cognitive Assessment Language - Repeat Test


name: Montreal Cognitive Assessment Language - Fluency Test


name: Montreal Cognitive Assessment Delayed Recall Test


name: Beclomethasone Dipropionate/Formoterol Fumarate Inhalation Solution


name: Submicron Particle Paclitaxel Sterile Suspension


name: BardPort Titanium Implanted Port with Peritoneal Catheter


name: Immune Effector Encephalopathy - ICE Assessment


name: INC Demographic and Maternal Terminology


name: Date of Neonatal Intensive Care Unit Admission


name: Mortality Cut-off Year, National Death Index


name: Stay Focused and Think Clearly Under Pressure Question


name: Have Pins and Needles in Your Arm Question


name: CDISC SEND Expected Onset of Rad/Nuc Targeted Injury Response Terminology


name: Fructosamine Corrected for Total Protein Measurement


name: Planned Challenge Agent Exposure Frequency


name: EORTC QLQ-C15-PAL Version 1 - Have You Felt Weak


name: EORTC QLQ-C30 Version 3 - Condition Caused Financial Difficulties


name: T1-DDS - Be Safe From Hypoglycemic Event


name: pH 10 Basic Reversed-Phase Liquid Chromatography


name: Nervous System Findings Group Identifier


name: Bifidobacterium longum/Lactobacillus acidophilus/Enterococcus faecalis Probiotic Supplement


name: Specify Number of Lymph Nodes Examined Question


name: Were Subsequent Known Primary Melanoma(s) Found During the Follow-Up Question


name: Cytogenetic Risk Group-CALGB Criteria for AML


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 10 g in 100 mL / OCTISALATE 4.5 g in 100 mL / OCTOCRYLENE 5.5 g in 100 mL / OXYBENZONE 5 g in 100 mL TOPICAL LOTION [Mary Kay Suncare SPF 50 Sunscreen]


name: TITANIUM DIOXIDE 22 mg in 1 mL / ZINC OXIDE 11 mg in 1 mL TOPICAL LOTION [Svens Everyday Mineral Sunscreen]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 100 mg in 1 g TOPICAL SPRAY [Neutrogena Beach Defense Water Plus Sun Protection Sunscreen Broad Spectrum SPF 50]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 80 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 80 mg in 1 g TOPICAL SPRAY [Neutrogena Beach Defense Water Plus Sun Protection Sunscreen Broad Spectrum SPF 30]


name: ALUMINUM SESQUICHLOROHYDRATE 17.6 g in 100 g TOPICAL AEROSOL, SPRAY [Degree]


name: LEVAMISOLE HYDROCHLORIDE 1 g in 1 g NOT APPLICABLE POWDER


name: TOLAZOLINE HYDROCHLORIDE 1 g in 1 g NOT APPLICABLE POWDER


name: CEFPODOXIME PROXETIL 1 g in 1 g NOT APPLICABLE POWDER


name: ZINC OXIDE 5.6695 g in 100 g / OCTISALATE 4.5 g in 100 g / OCTOCRYLENE 4.5 g in 100 g / HOMOSALATE 6 g in 100 g TOPICAL LOTION [Hawaiian Tropic Matte Effect Mineral Enriched Sunscreen SPF 30]


name: ALUMINUM SESQUICHLOROHYDRATE 24 g in 100 g TOPICAL AEROSOL, SPRAY [Antiperspirant Above Candy 1]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 159 mg in 1 g TOPICAL STICK [Lady Speed Stick Invisible Dry Power Spring Blossom - antiperspirant/deodorant]


name: ALUMINUM SESQUICHLOROHYDRATE 24 g in 100 g TOPICAL AEROSOL, SPRAY [Antiperspirant Above Dolce Vita]


name: DIMETHICONE 20 mg in 1 g / OCTINOXATE 75 mg in 1 g / OXYBENZONE 40 mg in 1 g TOPICAL STICK [Softlips Oasis Pineapple Coconut, Peach Mango, Strawberry Kiwi]


name: TEMOZOLOMIDE 1 g in 1 g NOT APPLICABLE POWDER


name: BUTYLSCOPOLAMINE BROMIDE 1 g in 1 g NOT APPLICABLE POWDER


name: ALUMINUM SESQUICHLOROHYDRATE 24 g in 100 g TOPICAL AEROSOL, SPRAY [Antiperspirant Above Teen Be Positive]


name: Avobenzone 30 mg in 1 mL / Homosalate 100 mg in 1 mL / Octisalate 50 mg in 1 mL / Octocrylene 50 mg in 1 mL / Oxybenzone 60 mg in 1 mL TOPICAL LOTION [La Roche Posay Laboratoire Dermatologique Anthelios 50 Daily Antiaging Primer with Sunscreen]


name: FAK Care4 Bus and School Yellow ORM D KIT


name: ALUMINUM SESQUICHLOROHYDRATE 24 g in 100 g TOPICAL AEROSOL, SPRAY [Antiperspirant Above Soft Creme]


name: ALUMINUM CHLOROHYDRATE 220 mg in 1 g TOPICAL STICK [Toms of Maine Coconut Lavender Antiperspriant / Deodorant]


name: ZINC OXIDE 83.4 mg in 1 g / TITANIUM DIOXIDE 10 mg in 1 g TOPICAL GEL [Blue Lizard Sensitive Face Sunscreen]


name: HYDROXYETHYL CELLULOSE (140 CPS AT 5%) 3.84 g in 240 mL TOPICAL OIL [WeDol Water-based personal lubricant]


name: ALUMINUM SESQUICHLOROHYDRATE 24 g in 100 g TOPICAL AEROSOL, SPRAY [Antiperspirant Above Sport Energy Women]


name: Niacinamide 0.60 g in 30 g / Adenosine 0.01 g in 30 g TOPICAL PATCH [Hyalu Plus Up Mask]


name: Niacinamide 0.60 g in 30 mL / Adenosine 0.01 g in 30 mL TOPICAL LIQUID [VIRGIN GRACE Hyalu Plus Serum]


name: ALUMINUM SESQUICHLOROHYDRATE 24 g in 100 g TOPICAL AEROSOL, SPRAY [Antiperspirant Above Elements Hurricane]


name: ALUMINUM CHLOROHYDRATE 220 mg in 1 g TOPICAL STICK [Toms of Maine for Men North Woods Antiperspriant Deodorant]


name: ZINC OXIDE 2.8 mg in 30 mL / TITANIUM DIOXIDE 4.3 mg in 30 mL TOPICAL LIQUID [Revlon Youth FX]


name: ALUMINUM SESQUICHLOROHYDRATE 24 g in 100 g TOPICAL AEROSOL, SPRAY


name: ALUMINUM SESQUICHLOROHYDRATE 24 g in 100 g TOPICAL AEROSOL, SPRAY [Antiperspirant Above Country]


name: ALUMINUM SESQUICHLOROHYDRATE 24 g in 100 g TOPICAL AEROSOL, SPRAY [Antiperspirant Above Fresh]


name: AVOBENZONE 3 g in 100 g / HOMOSALATE 9 g in 100 g / OCTISALATE 4.5 g in 100 g / OCTOCRYLENE 4 g in 100 g / OXYBENZONE 4.5 g in 100 g TOPICAL CREAM [TimeWise Repair VoluFirm Day Cream SPF 30 Broad Spectrum Sunscreen]


name: ZINC OXIDE 210 mg in 1 g TOPICAL CREAM [Prevention Plus Daily Tinted Moisturizer SPF 30]


name: AVOBENZONE 3 g in 100 g / HOMOSALATE 9 g in 100 g / OCTISALATE 4.5 g in 100 g / OCTOCRYLENE 4 g in 100 g / OXYBENZONE 4.5 g in 100 g TOPICAL CREAM [TimeWise Repair Volu-Firm Day Cream SPF 30 Broad Spectrum Sunscreen]


name: influenza A virus A/Kansas/14/2017 (H3N2) antigen / influenza A virus A/Switzerland/3330/2017 (H1N1) antigen / influenza B virus B/Colorado/06/2017 antigen / influenza B virus B/Phuket/3073/2013 antigen


name: camphor / menthol / methyl salicylate / methylsulfonylmethane


name: DRESSING,OPTIFOAM SITE 4IN X 4IN #MSC1104


name: CATHETER,INTERMITTENT 12FR FEMALE CURE #CQT12


name: CATHERIZATION SET,FOLEY 14FR BARD #772417


name: CATHETER,INTERMITTENT 12FR LOFRIC HYDRO-KIT COUDE #4251240


name: MASK,AEROSOL ADULT FACE TENT MEDLINE #HCS4630


name: TRACH ANTI-DISCONNECT DEVICE,SHILEY #SSDD


name: TUBING,SUCTION 1/4IN X 6FT COVIDIEN #8888301606


name: CATHETER FOLEY 3-WAY 18FR 5ML BARD #70518L


name: DRESSING,OPTIFOAM GENTLE POST-OP 4IN X 8IN #MSC2148


name: CATHETER,INTERMITTENT,GENTLECATH 16FR FEMALE #421574


name: SUCTION TUBE ATTACHMENT DEVICE CARDINAL #501015


name: ADAPTER,NEBULIZER VALVED CAREFUSION #2061


name: LEG BAG STRAP,SPORT,MEDIUM,UROCARE #6343


name: Medicare Chronic Condition Special Needs Plan (C-SNP)


name: Medicare Institutional Special Needs Plan (I-SNP)


name: Dual Eligible Special Needs Plan (D-SNP)


name: Fully Integrated Dual Eligible Special Needs Plan (FIDE-SNP)


name: SECNIDAZOLE 1 g in 1 g NOT APPLICABLE POWDER


name: AVOBENZONE 90 mg in 1 mL / HOMOSALATE 1000 mg in 1 mL / OCTISALATE 202.5 mg in 1 mL / OCTOCRYLENE 640 mg in 1 mL TOPICAL LOTION [Sunscreen]


name: OCTINOXATE 75 mg in 1 g / OCTISALATE 50 mg in 1 g / AVOBENZONE 30 mg in 1 g TOPICAL CREAM [Exuviance Daily Corrector with Sunsreen Broad Spectrum SPF 35]


name: TITANIUM DIOXIDE 70 mg in 1 mL / ZINC OXIDE 60 mg in 1 mL TOPICAL LOTION [Exuviance Skin Caring BB Fluid with Sunscreen Broad Spectrum SPF 50]


name: ZINC OXIDE 216 mg in 1 g TOPICAL STICK [Aveeno Kids Continuous Protection Sensitive Skin Mineral Sunscreen Broad Spectrum SPF 50]


name: ZINC OXIDE 216 mg in 1 g TOPICAL STICK [Neutrogena Sheer Zinc Kids Mineral Sunscreen Broad Spectrum SPF 50 Plus]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 19 g in 100 g TOPICAL STICK [Axe]


name: AVOBENZONE 30 mg in 1 g / OCTINOXATE 75 mg in 1 g / OCTISALATE 50 mg in 1 g TOPICAL CREAM [Exuviance Age Reverse Day Repair with Sunscreen Broad Spectrum SPF 30]


name: LIDOCAINE HYDROCHLORIDE 10 mg in 1 mL TOPICAL LIQUID [NATURES CRAFT LIDOCAINE Male Genital Desensitizer]


name: AVOBENZONE 25 mg in 1 mL / HOMOSALATE 60 mg in 1 mL / OCTISALATE 45 mg in 1 mL / OCTOCRYLENE 80 mg in 1 mL TOPICAL LOTION [Neutrogena Beach Defense Water Plus Sun Protection Sunscreen Broad Spectrum SPF30]


name: AVOBENZONE 25 mg in 1 mL / HOMOSALATE 80 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 80 mg in 1 mL TOPICAL LOTION [Neutrogena Clear Body Breakout Free Oil Free Sunscreen Broad Spectrum SPF 30]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL TOPICAL LOTION [Neutrogena Ultra Sheer Dry Touch Sunscreen Broad Spectrum SPF45]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL TOPICAL LOTION [Neutrogena Ultra Sheer Dry Touch Sunscreen Broad Spectrum SPF55]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 45 mg in 1 mL / OXYBENZONE 40 mg in 1 mL TOPICAL LOTION [Neutrogena Beach Defense Water Plus Sun Protection Sunscreen Broad Spectrum SPF 70]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 150 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL TOPICAL LOTION [Neutrogena Beach Defense Water Plus Sun Protection Sunscreen Broad Spectrum SPF50]


name: OCTISALATE 20 mg in 1 mL / OCTINOXATE 75 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL LOTION [Up and Up Illuminating Daily Moisturizer with Sunscreen Broad Spectrum SPF 15]


name: DIMETHICONE 20 mg in 1 g / OCTINOXATE 75 mg in 1 g / OCTISALATE 30 mg in 1 g / OXYBENZONE 30 mg in 1 g TOPICAL STICK [Softlips Vanilla Watermelon]


name: TITANIUM DIOXIDE 0.032 g in 1 mL / ZINC OXIDE 0.077 g in 1 mL TOPICAL CREAM [RECHARGE Protect Blur]


name: ZINC OXIDE 216 mg in 1 mL TOPICAL LOTION [Neutrogena Sheer Zinc Kids Mineral Sunscreen Broad Spectrum SPF 50 Plus]


name: HOMOSALATE 7 g in 100 g / OCTOCRYLENE 5 g in 100 g / AVOBENZONE 2 g in 100 g TOPICAL SPRAY [BANANA BOAT]


name: ISOPROTERENOL HYDROCHLORIDE 1 g in 1 g NOT APPLICABLE POWDER


name: TRAMETINIB 1 g in 1 g NOT APPLICABLE POWDER


name: AVOBENZONE 1.285 g in 50 mL / OCTINOXATE 3.8036 g in 50 mL / OCTOCRYLENE 1.542 g in 50 mL TOPICAL EMULSION [SHISEIDO WHITE LUCENT DAY]


name: TELMISARTAN 1 g in 1 g NOT APPLICABLE POWDER


name: CHLORAMPHENICOL PALMITATE 1 kg in 1 kg NOT APPLICABLE POWDER


name: CLEMASTINE FUMARATE 1 g in 1 g NOT APPLICABLE POWDER


name: OCTINOXATE 60 mg in 1 mL / OCTISALATE 40 mg in 1 mL / OXYBENZONE 35 mg in 1 mL TOPICAL CREAM [BB SPF20]


name: ZINC OXIDE 0.07 g in 1 g / TITANIUM DIOXIDE 0.0419 g in 1 g / OCTINOXATE 0.075 g in 1 g TOPICAL CREAM [MISSHA M Perfect Cover BB No 13]


name: ZINC OXIDE 0.07 g in 1 g / TITANIUM DIOXIDE 0.0419 g in 1 g / OCTINOXATE 0.075 g in 1 g TOPICAL CREAM [MISSHA M Perfect Cover BB No 21]


name: ZINC OXIDE 0.07 g in 1 g / TITANIUM DIOXIDE 0.0419 g in 1 g / OCTINOXATE 0.075 g in 1 g TOPICAL CREAM [MISSHA M Perfect Cover BB No 31]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL TOPICAL LOTION [Leader General Protection SPF 30 Sunscreen]


name: TITANIUM DIOXIDE 0.042 g in 1 g / ZINC OXIDE 0.07 g in 1 g / OCTINOXATE 0.075 g in 1 g TOPICAL CREAM [MISSHA M Perfect Cover BB SPF42 No23]


name: AVOBENZONE 20 mg in 1 g / HOMOSALATE 40 mg in 1 g / OCTISALATE 40 mg in 1 g / OCTOCRYLENE 20 mg in 1 g TOPICAL GEL [Neutrogena Hydro Boost City Shield water Broad Spectrum SPF 25]


name: {56 (elexacaftor 100 MG / ivacaftor 75 MG / tezacaftor 50 MG Oral Tablet) / 28 (ivacaftor 150 MG Oral Tablet) } Pack [Trikafta (100 MG / 50 MG / 75 MG; 150 MG)]


name: {30 (24 HR amantadine 129 MG Extended Release Oral Tablet [Osmolex]) / 30 (24 HR amantadine 193 MG Extended Release Oral Tablet [Osmolex]) } Pack [Osmolex 322 MG Daily Dosing]


name: {56 (elexacaftor 100 MG / ivacaftor 75 MG / tezacaftor 50 MG Oral Tablet) / 28 (ivacaftor 150 MG Oral Tablet) } Pack


name: {30 (24 HR amantadine 129 MG Extended Release Oral Tablet) / 30 (24 HR amantadine 193 MG Extended Release Oral Tablet) } Pack


name: hard maple pollen extract / red maple pollen extract


name: California black walnut pollen extract / English walnut pollen extract


name: oneseed juniper pollen extract / Rocky Mountain juniper pollen extract


name: CATHETER,INTERMITTENT COUDE 14FR COLOPLAST #20024


name: CATHETER,SUCTION 10FR MAXIFLO SMITHS #640010


name: CLEANSING CLOTH,ALOETOUCH PKT M#MSC095228


name: BANDAGE TUBULAR ELASTIC 4IN X 11YD SAG13115


name: DRESSING,ALLEVYN GENTLE BORDER LITE 7.5CM X 7.5CM #66020412


name: DRESSING,COLACTIVE PLUS AG 4IN X 4IN #10340000


name: DRESSING,CUTIMED SORBION SORBACT 4IN X 4IN #7269808


name: DRESSING,CUTIMED SORBION SORBACT 8IN X 12IN #7269811


name: DRESSING,HYDROFERA BLUE HEAVY DRAINAGE 6IN X 6IN HBHD6675


name: DRESSING,OPTIFOAM NON-ADHESIVE 3IN X 3IN #MSC1133F


name: DRESSING,POLYMEM MAX 3.5IN X 3.5IN,FERRIS #606


name: KIT PREP OF TECHNETUM TC-99 OXIDRONATE SODIUM INJ


name: KIT PREP OF TECHNETUM TC-99 TILMANOCEPT INJ


name: SALIVA,ARTIFICIAL (GC DRY MOUTH) GEL,DENT


name: AMINOCAPROIC ACID 1 g in 1 g NOT APPLICABLE POWDER


name: Avobenzone 30 mg in 1 g / Octisalate 50 mg in 1 g / Octocrylene 70 mg in 1 g TOPICAL CREAM [Lancome Paris Renergie Lift MultiAction Ultra Lifting Firming Dark Spot Correcting Broad Spectrum SPF 30 Sunscreen]


name: OCTINOXATE 75 mg in 1 mL / TITANIUM DIOXIDE 32 mg in 1 mL TOPICAL LIQUID [Lancome Paris Renergie Lift Makeup Broad Spectrum SPF 27 Sunscreen]


name: OCTINOXATE 75 mg in 1 mL TOPICAL LIQUID [Lancome Paris Renergie Lift Makeup Broad Spectrum SPF 26 Sunscreen]


name: OCTINOXATE 75 mg in 1 g / OXYBENZONE 50 mg in 1 g TOPICAL LIPSTICK [Neutrogena Revitalizing Lip Balm SPF 20 - Fresh Plum 60]


name: TITANIUM DIOXIDE 2.05 mg in 50 mL / ZINC OXIDE 5.75 mg in 50 mL TOPICAL CREAM [Dr.Jart Every Sun Day Mineral Sun Screen]


name: ZINC OXIDE 240 mg in 1 mL TOPICAL LOTION [MUSTELA MINERAL SUNSCREEN BROAD SPECTRUM SPF 50]


name: BASIC FIBROBLAST GROWTH FACTOR (HUMAN) 0.001 g in 100 mL TOPICAL LIQUID [Oliglo Multi-Action Peptide Gel Pack]


name: GREEN TEA LEAF 1.2 g in 100 mL TOPICAL LIQUID [Oliglo Lifting Serum]


name: AVOBENZONE 27 mg in 1 mL / HOMOSALATE 40 mg in 1 mL / OCTISALATE 45 mg in 1 mL / OCTOCRYLENE 60 mg in 1 mL / OXYBENZONE 45 mg in 1 mL TOPICAL LOTION [Neutrogena Clear Face Breakout Free Oil Free Broad Spectrum SPF 55]


name: Titanium Dioxide 85.4 mg in 1 mL / Zinc Oxide 40.7 mg in 1 mL TOPICAL CREAM [TiZO2]


name: AVOBENZONE 90 mg in 1 g / HOMOSALATE 225 mg in 1 g / OCTISALATE 250 mg in 1 g / OCTOCRYLENE 1000 mg in 1 g TOPICAL SPRAY [Sunscreen]


name: TITANIUM DIOXIDE 10 mg in 1 mL / ZINC OXIDE 200 mg in 1 mL TOPICAL CREAM [ZO Skin Health Sunscreen Plus Primer Broad-Spectrum SPF 30]


name: CIPROFLOXACIN HYDROCHLORIDE 1 g in 1 g NOT APPLICABLE POWDER


name: ZINC OXIDE 200 mg in 1 g TOPICAL CREAM [CoTZ Flawless Complexion]


name: ZINC OXIDE 200 mg in 1 g TOPICAL CREAM [TiZO Ultra Zinc SPF 40 (Tinted)]


name: OCTISALATE 5 g in 100 mL / AVOBENZONE 3 g in 100 mL / OCTOCRYLENE 10 g in 100 mL TOPICAL LOTION [Hand Screen Broad Spectrum Sunscreen SPF 40]


name: DICLAZURIL 1 g in 1 g NOT APPLICABLE POWDER


name: IDOXURIDINE 1 g in 1 g NOT APPLICABLE POWDER


name: OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 50 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL CREAM [AMBI SKINCARE Even and Clear Daily Facial Moisturizer SPF 30]


name: OCTINOXATE 75 mg in 1 g / OCTISALATE 50 mg in 1 g / OXYBENZONE 30 mg in 1 g / TITANIUM DIOXIDE 67.4 mg in 1 g TOPICAL CREAM [COVER plus CORRECT/TINTED MOISTURIZER CC CRM FAIR]


name: AVOBENZONE 3 g in 100 g / HOMOSALATE 15 g in 100 g / OCTISALATE 5 g in 100 g / OCTOCRYLENE 8 g in 100 g TOPICAL SPRAY [TRADER JOES SUNSCREEN SPF 50]


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 10 g in 100 mL / OCTISALATE 5 g in 100 mL / OCTOCRYLENE 7 g in 100 mL TOPICAL LOTION [TRADER JOES FACE AND BODY SUNSCREEN SPF 30]


name: Octinoxate 0.065 g in 1 g / Titanium Dioxide 0.0244 g in 1 g / Zinc Oxide 0.0157 g in 1 g TOPICAL PASTE [LBEL MOUSSE MATIFFIANT MATTE FINISH MOUSSE FOUNDATION SPF 15 Claire 1/Beige]


name: Octinoxate 0.065 g in 1 g / Titanium Dioxide 0.0244 g in 1 g / Zinc Oxide 0.0157 g in 1 g TOPICAL PASTE [LBEL MOUSSE MATIFFIANT MATTE FINISH MOUSSE FOUNDATION SPF 15 Claire 2/ Beige]


name: Octinoxate 0.065 g in 1 g / Titanium Dioxide 0.0244 g in 1 g / Zinc Oxide 0.0157 g in 1 g TOPICAL PASTE [LBEL MOUSSE MATIFFIANT MATTE FINISH MOUSSE FOUNDATION SPF 15 Claire 3/ Beige]


name: Octinoxate 0.065 g in 1 g / Titanium Dioxide 0.0244 g in 1 g / Zinc Oxide 0.0157 g in 1 g TOPICAL PASTE [LBEL MOUSSE MATIFFIANT MATTE FINISH MOUSSE FOUNDATION SPF 15 Claire 4/ Beige]


name: Zinc Oxide 200 mg in 1 g TOPICAL CREAM [CoTZ Baby]


name: GLYCERIN 2 g in 100 mL TOPICAL LOTION [Zenibell Snail Intensive]


name: LIDOCAINE 10 mg in 1 mL TOPICAL OINTMENT [Prolayed Lidocaine Male Genital Desensitizer]


name: OCTOCRYLENE 6.5 g in 100 g / AVOBENZONE 2.7 g in 100 g / HOMOSALATE 9 g in 100 g / OCTISALATE 4.5 g in 100 g TOPICAL LOTION [Banana Boat Ultra Sport Sunscreen Broad Spectrum SPF 50]


name: LOSARTAN POTASSIUM 1 g in 1 g NOT APPLICABLE POWDER


name: OCTINOXATE 7 g in 100 g / TITANIUM DIOXIDE 7.6 g in 100 g / ZINC OXIDE 3.6 g in 100 g TOPICAL CREAM [TOM FORD SHADE AND ILLUMINATE FOUNDATION BROAD SPECTRUM SPF 45 SOFT RADIANCE CUSHION COMPACT REFILL]


name: OCTOCRYLENE 3 g in 100 g / OXYBENZONE 4 g in 100 g / HOMOSALATE 10 g in 100 g / OCTISALATE 5 g in 100 g / AVOBENZONE 3 g in 100 g TOPICAL SPRAY [Hawaiian Tropic Silk Hydration Clear Sunscreen Broad Spectrum SPF 50]


name: AVOBENZONE 90 mg in 1 mL / HOMOSALATE 2250 mg in 1 mL / OCTISALATE 250 mg in 1 mL / OCTOCRYLENE 1000 mg in 1 mL TOPICAL LOTION [SUNSCREEN]


name: GLYCERIN 2 g in 100 g TOPICAL CREAM [Zenibell Snail IntensiveCream]


name: GLYCERIN 2 g in 100 mL TOPICAL LIQUID [Zenibell Snail Intensive Toner]


name: PETROLATUM 86 mg in 1 g TOPICAL OINTMENT [Resurfix Plus]


name: allantoin / benzocaine / camphor / dimethicone / menthol / petrolatum


name: CATHETER,INTERMITTENT 18FR LOFRIC HYDRO-KIT #4201840


name: CATHETER,INTERMITTENT COUDE 12FR LOFRIC PRIMO #4151240


name: CATHETER,INTERMITTENT,GENTLECATH 16FR FEMALE #501023


name: FEEDING BAG W/PUMP SET ENFIT COVIDIEN #772055


name: Regurgitant blood flow pressure half-time


name: Gene product metabolic activity interpretation


name: IRF-PAI v3.0, LCDS v4.00, OASIS E - Health conditions - discharge or expired or transfer


name: LCDS v4.00 - Signs and Symptoms of Delirium (from CAM)


name: LCDS v4.00 - Self-care - discharge performance


name: LCDS v3.00 - Bladder and bowel - planned discharge


name: LCDS v4.00 - Self-care - admission performance


name: LCDS v4.00 - Skin conditions - discharge


name: LCDS v4.00 - Spontaneous breathing trial


name: MDS v3.0 - RAI v1.17.2 - Optional state assessment


name: Outcome and assessment information set (OASIS) form - version D1:-:RptPeriod:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version D1


name: OASIS D1 - Patient history and diagnoses - follow-up:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS D1 - Patient history and diagnoses - follow-up


name: OASIS D1 - ADL and IADLs - follow-up:-:RptPeriod:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version D1 - Follow-up - recertification or other follow-up:-:RptPeriod:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version D1 - Follow-up - recertification or other follow-up


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about the effect of ongoing health problems such as high blood pressure or diabetes on your pregnancy:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about the effect of ongoing health problems such as high blood pressure or diabetes on your pregnancy


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about feeling tired and having low energy during your pregnancy:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about feeling tired and having low energy during your pregnancy


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about paying for your medical care during pregnancy:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about paying for your medical care during pregnancy


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about changes in your weight and body shape during pregnancy:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about changes in your weight and body shape during pregnancy


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about whether you might have an unhealthy baby:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about whether you might have an unhealthy baby


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as vomiting:Find:Pt:^Patient:Ord:NuMoM2b


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as vomiting


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as swollen feet:Find:Pt:^Patient:Ord:NuMoM2b


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as swollen feet


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as backaches:Find:Pt:^Patient:Ord:NuMoM2b


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as backaches


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about the quality of your medical care during pregnancy:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about the quality of your medical care during pregnancy


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about working or caring for your family during your pregnancy:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about working or caring for your family during your pregnancy


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about whether the baby might be affected by alcohol, cigarettes, or drugs that you have taken:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about whether the baby might be affected by alcohol, cigarettes, or drugs that you have taken


name: Are there other things that you are bothered, upset or worried about that have to do with your pregnancy, the birth, or the baby:Find:Pt:^Patient:Ord:NuPDQ


name: Are there other things that you are bothered, upset or worried about that have to do with your pregnancy, the birth, or the baby


name: Other things you are feeling bothered, upset or worried about:Find:Pt:^Patient:Nom:NuPDQ


name: Other things you are feeling bothered, upset or worried about


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about paying for the baby's clothes, food, or medical care:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about paying for the baby's clothes, food, or medical care


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about taking care of a newborn baby:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about taking care of a newborn baby


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about pain during labor and delivery:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about pain during labor and delivery


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about whether the baby might come too early:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about whether the baby might come too early


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as vomiting, swollen feet, or backaches:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as vomiting, swollen feet, or backaches


name: Physical symptom of pregnancy that you are feeling bothered, upset or worried about:Find:Pt:^Patient:Nom:NuPDQ


name: Physical symptom of pregnancy that you are feeling bothered, upset or worried about


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about changes in your relationships with other people due to having a baby:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about changes in your relationships with other people due to having a baby


name: Person who you are feeling bothered, upset or worried about having a relationship change with due to having a baby:Find:Pt:^Patient:Nom:NuPDQ


name: Person who you are feeling bothered, upset or worried about having a relationship change with due to having a baby


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about what will happen during labor and delivery:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about what will happen during labor and delivery


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about working at a job after the baby comes:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about working at a job after the baby comes


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about getting day care, babysitters, or help to watch the baby after it comes:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about getting day care, babysitters, or help to watch the baby after it comes


name: Revised Prenatal Distress Questionnaire - Concurrent Self-Administered Version:-:Pt:^Patient:-:NuPDQ


name: Revised Prenatal Distress Questionnaire - Concurrent Self-Administered Version


name: Nulliparous Pregnancy Outcomes Study Monitoring Mothers-to-Be Difficulties in Pregnancy form:-:Pt:^Patient:-:NuMoM2b


name: Nulliparous Pregnancy Outcomes Study Monitoring Mothers-to-Be Difficulties in Pregnancy form


name: Quality of Working Life Questionnaire for Cancer Survivors:-:4W:^Patient:-:QWLQ-CS


name: Quality of Working Life Questionnaire for Cancer Survivors


name: During the past 4W, working gives me structure in my life:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, working gives me structure in my life


name: During the past 4W, I think it is good to work:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I think it is good to work


name: During the past 4W, I consider that my work gives me a goal in life:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I consider that my work gives me a goal in life


name: During the past 4W, I consider my work important:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I consider my work important


name: During the past 4W, I do my work well:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I am self-confident in my work:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I am self-confident in my work


name: During the past 4W, I am suited to my work:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I am suited to my work


name: During the past 4W, I have control over the work I do:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I have control over the work I do


name: During the past 4W, I feel powerless in my work:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I feel powerless in my work


name: During the past 4W, I feel there is a positive atmosphere in my working environment:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I feel there is a positive atmosphere in my working environment


name: During the past 4W, I have the feeling I am taken seriously by people in my working environment:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I have the feeling I am taken seriously by people in my working environment


name: During the past 4W, I am content with my work:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I am content with my work


name: During the past 4W, I have good relations with my colleagues:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I have good relations with my colleagues


name: During the past 4W, I feel valuable to my colleagues:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I feel valuable to my colleagues


name: During the past 4W, my immediate superior understands my health situation and possible health problems:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, my immediate superior understands my health situation and possible health problems


name: During the past 4W, I have good relations with my immediate superior:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I have good relations with my immediate superior


name: During the past 4W, I consider that employees with health problems are treated well in my organization:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I consider that employees with health problems are treated well in my organization


name: During the past 4W, I am content with the fringe benefits provided by my employer:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I am content with the fringe benefits provided by my employer


name: During the past 4W, I am content with my current income:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I am content with my current income


name: During the past 4W, because of my health situation I have problems in my work with fatigue AndOr lack of energy:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, because of my health situation I have problems in my work with fatigue AndOr lack of energy


name: During the past 4W, I am limited in my work:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I am limited in my work


name: During the past 4W, because of my health situation I have little trust in my own body:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, because of my health situation I have little trust in my own body


name: During the past 4W, because of my health situation I feel uncertain about the future:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, because of my health situation I feel uncertain about the future


name: Perception of your work situation:-:4W:^Patient:-:QWLQ-CS


name: Atmosphere in your working environment:-:4W:^Patient:-:QWLQ-CS


name: Understanding and recognition in your organization:-:4W:^Patient:-:QWLQ-CS


name: Understanding and recognition in your organization


name: Problems due to your health situation:-:4W:^Patient:-:QWLQ-CS


name: Difficulties in Pregnancy total score:Score:Pt:^Patient:Qn:NuMoM2b


name: Dark-mediated rod adaptation time:Time:Pt:Eye.right:Qn


name: Dark-mediated rod adaptation time:Time:Pt:Eye.left:Qn


name: New York Heart Association Functional Classification:-:Pt:^Patient:-:NYHA


name: New York Heart Association Functional Classification


name: Sit to stand^with use of upper extremities:NRat:30S:^Patient:Qn


name: Inpatient Rehabilitation Facility - Patient Assessment Instrument - version 4.0:-:RptPeriod:^Patient:-:CMS Assessment


name: Inpatient Rehabilitation Facility - Patient Assessment Instrument - version 4.0


name: Bone development stage:Score:Pt:Upper extremity>Radius:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Wrist.trapezoid:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Wrist.trapezium:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Wrist.scaphoid:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Wrist.lunate:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Wrist.triquetrum:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Wrist.hamate:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Wrist.capitate:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Thumb.distal phalanx:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Finger.fifth.distal phalanx:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Finger.third.distal phalanx:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Finger.third.middle phalanx:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Finger.fifth.middle phalanx:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Finger.fifth.proximal phalanx:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Finger.third.proximal phalanx:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Thumb.proximal phalanx:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Hand.metacarpal.fifth:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Hand.metacarpal.third:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Hand.metacarpal.first:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Ulna:Qn:XR


name: Drug classes that have an indication documented:Type:RptPeriod:^Patient:Nom:CMS Assessment


name: Drug classes that have an indication documented


name: IRF-PAI v4.0, LCDS v5.00, OASIS E - High risk drug classes - use and indication:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0, LCDS v5.00, OASIS E - High risk drug classes - use and indication


name: How much of the time has pain made it hard for you to sleep at night:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: How often do you need to have someone help you when you read instructions, pamphlets, or other written material from your doctor or pharmacy:Find:Pt:^Patient:Ord:OASIS


name: How Often Need Help Reading Instructions, Pamphlets, or other Written Material from Doctor or Pharmacy Question


name: How often have you limited your day-to-day activities because of pain:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: How often do you feel lonely or isolated from those around you:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: How often do you feel lonely or isolated from those around you


name: How often have you limited your participation in rehabilitation therapy sessions due to pain over:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: IRF-PAI v4.0 - Administrative information:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Administrative information


name: IRF-PAI v4.0 - Cognitive patterns - admission:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Cognitive patterns - admission


name: IRF-PAI v4.0 - Cognitive patterns - discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Cognitive patterns - discharge


name: IRF-PAI v4.0 - Health conditions - admission:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Health conditions - admission


name: IRF-PAI v4.0 - Hearing, speech, and vision - admission:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Hearing, speech, and vision - admission


name: IRF-PAI v4.0, OASIS E - Hearing, speech, and vision - ROC, DC:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0, OASIS E - Hearing, speech, and vision - ROC, DC


name: IRF-PAI v4.0 - Identification information:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Identification information


name: IRF-PAI v4.0, LCDS v5.00 - Medications - admission:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0, LCDS v5.00 - Medications - admission


name: IRF-PAI v4.0, LCDS v5.00 - Medications - discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0, LCDS v5.00 - Medications - discharge


name: IRF-PAI v4.0, LCDS v5.00, OASIS E - Mood:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0, LCDS v5.00, OASIS E - Mood


name: IRF-PAI v4.0 - Quality indicators - admission:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Quality indicators - admission


name: IRF-PAI v4.0 - Quality indicators - discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Quality indicators - discharge


name: IRF-PAI v4.0 - Special treatments, procedures, and programs - admission:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Special treatments, procedures, and programs - admission


name: IRF-PAI v4.0 - Special treatments, procedures, and programs - discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Special treatments, procedures, and programs - discharge


name: IRF-PAI v4.0 - Swallowing &or nutritional status - admission:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Swallowing &or nutritional status - admission


name: IRF-PAI v4.0, LCDS v5.00 - Swallowing &or nutritional status - discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0, LCDS v5.00 - Swallowing &or nutritional status - discharge


name: IRF-PAI v4.0, LCDS v5.00 - Health conditions - discharge or expired:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0, LCDS v5.00 - Health conditions - discharge or expired


name: IRF-PAI v4.0, LCDS v5.00 - Nutritional approaches - last 7D and discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0, LCDS v5.00 - Nutritional approaches - last 7D and discharge


name: Provision of current reconciled medication list to patient at discharge:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Provision of current reconciled medication list to patient at discharge


name: Provision of current reconciled medication list to subsequent provider at discharge:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Provision of current reconciled medication list to subsequent provider at discharge


name: Route of current reconciled medication list transmission to patient:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Route of current reconciled medication list transmission to patient


name: Route of current reconciled medication list transmission to subsequent provider:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Route of current reconciled medication list transmission to subsequent provider


name: Special treatments, procedures, and programs at discharge:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Special treatments, procedures, and programs at discharge


name: Preferred language & interpreter need:-:Pt:^Patient:-


name: IRF-PAI v4.0 - Administrative information - discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Administrative information - discharge


name: Total skeletal maturity score:Score:Pt:Upper extremity>Wrist+Hand:Qn:XR


name: TPMT gene & NUDT15 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen